JOGC

Managing Menopause Chapter 8 Sexuality and Menopause

        In gynaecologic practice many peri- and postmenopausal women present to the physician with new complaints of changes in sexual desire or pain with intercourse that affects their relationships and quality of life.
        • Leiblum S.
        • Koochaki P.
        • Rodenberg C.
        • Barton I.
        • Rosen R.
        Hypoactive sexual desire disorder in postmenopausal women. US results from the Women’s International Study of Health on Sexuality (WISHeS).
        • Davison S.L.
        • Bell R.J.
        • LaChina M.
        • Holden S.L.
        • Davis S.R.
        The relationship between self-reported sexual satisfaction and general well-being in women.
        Postmenopausal women are interested in sex for physical pleasure, intimacy, and expression of love, as well as to please their partner.
        • Lamont J.
        Female sexual health consensus clinical guidelines.
        Maintenance of sexuality is important for the well-being of women as they navigate the emotional and physical challenges of menopause.
        • Davison S.L.
        • Bell R.J.
        • LaChina M.
        • Holden S.L.
        • Davis S.R.
        The relationship between self-reported sexual satisfaction and general well-being in women.
        • Basson R.
        Sexual concerns — menopause and sexual function.
        The most commonly reported sexual problems in mid-life women are loss of libido and dyspareunia.
        • Davison S.L.
        • Bell R.J.
        • LaChina M.
        • Holden S.L.
        • Davis S.R.
        The relationship between self-reported sexual satisfaction and general well-being in women.
        • West S.L.
        • D’Aloisio A.A.
        • Agans R.P.
        • Kalsbeek W.D.
        • Borissov N.N.
        • Thorp J.M.
        Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.
        • Nappi R.E.
        • Davis S.R.
        The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI.
        Although 52% of naturally menopausal women versus 27% of premenopausal women report low sexual desire,
        • West S.L.
        • D’Aloisio A.A.
        • Agans R.P.
        • Kalsbeek W.D.
        • Borissov N.N.
        • Thorp J.M.
        Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.
        only 10% to 15% of women are distressed by their sexual problems.
        • Shifren J.L.
        • Monz B.U.
        • Russo P.A.
        • Segreti A.
        • Johannes C.B.
        Sexual problems and distress in United States women: prevalence and correlates.
        As well, up to 50% of women report vaginal discomfort within 3 years of menopause.
        • Sturdee D.W.
        • Panay N.
        • International Menopause Society Writing Group
        Recommendations for the management of postmenopausal vaginal atrophy.
        To read this article in full you will need to make a payment

        REFERENCES

          • Leiblum S.
          • Koochaki P.
          • Rodenberg C.
          • Barton I.
          • Rosen R.
          Hypoactive sexual desire disorder in postmenopausal women. US results from the Women’s International Study of Health on Sexuality (WISHeS).
          Menopause. 2006; 13: 46-56
          • Davison S.L.
          • Bell R.J.
          • LaChina M.
          • Holden S.L.
          • Davis S.R.
          The relationship between self-reported sexual satisfaction and general well-being in women.
          J Sex Med. 2009; 6: 2690-2697
          • Lamont J.
          Female sexual health consensus clinical guidelines.
          J Obstet Gynaecol Can. 2012; 34: S1-S60
          • Basson R.
          Sexual concerns — menopause and sexual function.
          in: Bélisle S. Blake J. SOGC Menopause Guidelines Committee Canadian Consensus Conference on Menopause, 2006 update. SOGC Clinical Practice Guidelines, No. 171, February 2006. J Obstet Gynaecol Can. 28. 2006: S43-S52
          • West S.L.
          • D’Aloisio A.A.
          • Agans R.P.
          • Kalsbeek W.D.
          • Borissov N.N.
          • Thorp J.M.
          Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.
          Arch Intern Med. 2008; 168: 1441-1449
          • Avis N.E.
          • Brockwell S.
          • Randolph Jr., J.F.
          • Shen S.
          • Cain V.S.
          • Ory M.
          • et al.
          Longitudinal changes in sexual functioning as women transition through menopause; results from the study of Women’s Health Across the Nation.
          Menopause. 2009; 16: 442-452
          • Lindau S.T.
          • Schumm P.
          • Laumann E.O.
          • Levinson W.
          • Muircheartaigh C.A.
          • Waite L.J.
          A study of sexuality and health among older adults in the United States.
          N Engl J Med. 2007; 357: 762-774
          • Shifren J.L.
          • Monz B.U.
          • Russo P.A.
          • Segreti A.
          • Johannes C.B.
          Sexual problems and distress in United States women: prevalence and correlates.
          Obstet Gynecol. 2008; 112: 970-978
          • Shifren J.L.
          Increasing our understanding of women’s sexuality at midlife and beyond.
          Menopause. 2011; 18: 1149-1151
          • Nappi R.E.
          • Davis S.R.
          The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI.
          Climacteric. 2012; 15: 267-274
          • Sturdee D.W.
          • Panay N.
          • International Menopause Society Writing Group
          Recommendations for the management of postmenopausal vaginal atrophy.
          Climacteric. 2010; 13 (Epub 2010 Sep 30): 509-522
          • Laumann E.O.
          • Waite L.J.
          Sexual dysfunction among older adults: prevalence and risk factors from a nationally representative US probability sample of men and women 57–85 years of age.
          J Sex Med. 2008; 5: 2300-2311
          • Salonia A.
          • Zanni G.
          • Nappi R.E.
          • Briganti A.
          • Dehò F.
          • Fabbri F.
          • et al.
          Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study.
          Eur Urol. 2004; 45: 642-648
          • Dennerstein L.
          • Lehert P.
          • Berger H.
          The relative effect of hormones and relationship factors on sexual function of women through the natural menopausal transition.
          Fertil Steril. 2005; 84: 174-180
          • Gracia C.R.
          • Freeman E.W.
          • Sammel M.D.
          • Lin H.
          • Mogul M.
          Hormones and sexuality during transition to menopause.
          Obstet Gynecol. 2007; 109: 831-840
          • Davison S.L.
          • Bell R.J.
          • LaChina M.
          • Holden S.L.
          • Davis S.R.
          Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status.
          J Sex Med. 2008; 5: 1214-1222
          • Prairie B.A.
          • Scheier M.F.
          • Matthews K.A.
          • Chang C.C.
          • Hess R.
          A higher sense of purpose in life is associated with sexual enjoyment in midlife women.
          Menopause. 2011; 18: 39-844
          • Hess R.
          • Conroy M.B.
          • Ness R.
          • Bryce C.L.
          • Dillon S.
          • Chang C.C.
          • et al.
          Association of lifestyle and relationship factors with sexual functioning of women during midlife.
          J Sex Med. 2009; 6: 1358-1368
          • Nappi R.E.
          • Albani F.
          • Santamaria V.
          • Tonani S.
          • Magri F.
          • Martini E.
          • et al.
          Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause.
          Maturitas. 2010; 67 (Epub 2010 Jun 16): 78-83
          • Laumann E.O.
          • Paik A.
          • Glasser D.B.
          • Kang J.H.
          • Wang T.
          • Levinson B.
          • et al.
          A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitude and Behaviors.
          Arch Sex Behav. 2006; 2 (Epub 2006 Apr 26): 145-161
          • Chedraui P.
          • Perez-Lopez F.R.
          • San Miguel G.
          • Avila C.
          Assessment of sexuality among middle-aged women using the Female Sexual Function Index.
          Climacteric. 2009; 12: 213-221
          • Blümel J.E.
          • Chedraui P.
          • Baron G.
          • Belzares E.
          • Bencosme A.
          • Calle A.
          • et al.
          Sexual dysfunction in middle-aged women: a multicenter Latin American study using the Female Sexual Function Index.
          Menopause. 2009; 16: 1139-1148
          • Nappi R.E.
          • Nijland E.A.
          Women’s perception of sexuality around the menopause: outcomes of a European telephone survey.
          Eur J Obstet Gynecol Reprod Biol. 2008; 137 (Epub 2007 Jan 4): 10-16
          • Graziottin A.
          Prevalence and evaluation of sexual health problems— HSDD in Europe.
          J Sex Med. 2007; 4: 211-219
          • Gass M.L.
          • Cochrane B.B.
          • Larson J.C.
          • Manson J.E.
          • Barnabei V.M.
          • Brzyski R.G.
          • et al.
          Patterns and predictors of sexual activity among women in the hormone therapy trials of the Women’s Health Initiative.
          Menopause. 2011; 18: 1160-1171
          • Basson R.
          • Rees P.
          • Wang R.
          • Montejo A.L.
          • Incrocci L.
          Sexual function in chronic illness.
          J Sex Med. 2010; 7: 374-388
          • Allahdadi K.J.
          • Tostes R.C.
          • Webb R.C.
          Female sexual dysfunction: therapeutic options and experimental challenges.
          Cardiovasc Hematol Agents Med Chem. 2009; 7: 260-269
          • Copeland K.L.
          • Brown J.S.
          • Creasman J.M.
          • Van Den Eeden S.K.
          • Subak L.L.
          • Thom D.H.
          • et al.
          Diabetes mellitus and sexual function in middle-aged and older women.
          Obstet Gynecol. 2012; 120: 331-340
          • Serretti A.
          • Chiesa A.
          Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
          J Clin Psychopharmacol. 2009; 29: 259-266
          • McCall-Hosenfeld J.S.
          • Jaramillo S.A.
          • Legault C.
          • Freund K.M.
          • Cochrane B.B.
          • Manson J.E.
          • et al.
          Correlates of sexual satisfaction among sexually active postmenopausal women in the Women’s Health Initiative—observational study.
          J Gen Intern Med. 2008; 23 (Epub 2008 Oct 7): 2000-2009
          • Castelo-Branco C.
          • Palacios S.
          • Combalia J.
          • Ferrer M.
          • Traveria G.
          Risk of hypoactive sexual desire disorder and associated factors in a cohort of oophorectomized women.
          Climacteric. 2009; 12: 525-532
          • Shifren J.L.
          • Avis N.E.
          Surgical menopause: effects on psychological well-being and sexuality.
          Menopause. 2007; 14: 586-591
          • Trompeter S.
          • Bettencourt R.
          • Barrett-Connor E.
          Sexual activity and satisfaction in healthy community-dwelling older women.
          Am J Med. 2012; 125: 37-43
          • Buster J.
          • Kingsberg S.
          • Kilpatrick C.
          Female sexual dysfunction [practice bulletin].
          Ob-Gyn. 2011; 119: 996-1003
          • Stahl S.
          Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder.
          J Clin Psychiatry. 2010; 71: 821-822
          • Pfaus J.G.
          Pathways of sexual desire.
          J Sex Med. 2009; 6: 1506-1533
          • Salonia A.
          • Giraldi A.
          • Chivers M.L.
          • Georgiadis J.R.
          • Levin R.
          • Maravilla K.R.
          • et al.
          Physiology of women’s sexual function; basic knowledge and new findings.
          J Sex Med. 2010; 8: 2637-2660
          • World Health Organization
          International Statistical Classification of Diseases and Related Health Problems, 10th rev.
          World Health Organization, Geneva1992
          • American Psychiatric Association
          Diagnostic and Statistical Manual of Mental Disorders, 5th ed, text rev.
          American Psychiatric Association, Washington, DC2013
          • Basson R.
          • Berman J.
          • Burnett A.
          • Derogatis L.
          • Ferguson D.
          • Fourcroy J.
          • et al.
          Report of the International Consensus Development Conference on Female Sexual Dysfunction: definitions and classifications.
          J Urol. 2000; 163: 888-893
          • Basson R.
          Is it time to move on from “hypoactive sexual desire disorder”?.
          Menopause. 2010; 17: 1097-1098
          • Davison S.L.
          • Bell R.
          • Donath S.
          • Montalto J.G.
          • Davis S.R.
          Androgen levels in adult females: changes with age, menopause, and oophorectomy.
          J Clin Endocrinol Metab. 2005; 90: 3847-3953
          • Labrie F.
          • Marel C.
          • Bulser J.
          Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: Role of the ovary?.
          Menopause. 2011; 18: 30-43
          • Davis S.R.
          • Burger H.G.
          The role of androgen therapy.
          Best Pract Res Clin Endocrinol Metab. 2003; 17: 165-175
          • Basson R.
          • Brotto L.
          • Petkau A.
          • Fernand L.
          Role of androgens in women’s sexual dysfunction.
          Menopause. 2010; 17: 962-971
        1. 2012 Hormone Therapy Position Statement of the North American Menopause Society.
          Menopause. 2012; 19: 257-271
          • Nappi R.E.
          • Polatti F.
          The use of estrogen therapy in women’s sexual function.
          J Sex Med. 2009; 6: 603-616
          • Al-Azzawi F.
          • Bitzer J.
          • Brandenburg U.
          • Castelo-Branco C.
          • Graziottin A.
          • Kenemans P.
          • et al.
          Therapeutic options for postmenopausal female sexual dysfunction.
          Climacteric. 2010; 13: 103-120
          • Archer D.
          Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
          Menopause. 2010; 17: 194-203
          • Modelska K.
          • Litwach S.
          • Ewing S.K.
          • Yaffe K.
          Endogenous estrogen levels affect sexual function in elderly post-menopausal women.
          Maturitas. 2004; 49: 124-133
          • Tan O.
          • Bradshaw K.
          • Carr B.
          Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
          Menopause. 2012; 19: 109-117
          • Levine K.B.
          • Williams R.E.
          • Hartmann K.E.
          Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women.
          Menopause. 2008; 15: 661-667
          • Sarrel P.
          Sexual dysfunction: treat or refer.
          Obstet Gynecol. 2005; 106: 834-839
          • Martin-Morales A.
          • Graziottin A.
          • Jaoude G.B.
          • Debruyne F.
          • Buvat J.
          • Beneke M.
          • et al.
          Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study.
          J Sex Med. 2011; 8: 2831-2840
          • Thase M.E.
          • Clayton A.H.
          • Haight B.R.
          • Thompson A.H.
          • Modell J.G.
          • Johnston J.A.
          A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
          J Clin Psychopharmacol. 2006; 26: 482-488
          • Basson R.
          Sexuality and sexual disorders.
          Clinical Updates in Women’s Health Care. American College of Obstetricians and Gynecologists, Washington, DC2014: 50-53
          • Kingsberg S.
          The Hypoactive Sexual Desire Disorder Registry to characterize the natural history and outcomes of women with hypoactive sexual desire disorder.
          Menopause. 2012; 19: 379-381
          • Sturdee D.W.
          • Pines A.
          • International Menopause Society Writing Group
          Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health.
          Climacteric. 2011; 14: 302-320
          • Suckling J.
          • Lethaby A.
          • Kennedy R.
          Local oestrogen for vaginal atrophy in postmenopausal women (review).
          Cochrane Database Syst Rev. 2006; 4: CD001500
          • The North American Menopause Society
          The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
          Menopause. 2007; 14: 355-369
          • Gast M.J.
          • Freedman M.A.
          • Vieweg A.J.
          • De Melo N.R.
          • Girao M.J.
          • Zinaman M.J.
          • The Dyspareunia Study Group
          A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
          Menopause. 2009; 16: 247-256
          • Panay N.
          • Fenton A.
          The role of testosterone in women.
          Climacteric. 2009; 12: 185-187
          • Somboonporn W.
          • Davis S.
          • Seif M.W.
          • Bell R.
          Testosterone for peri- and postmenopausal women.
          Cochrane Database Syst Rev. 2005; 4: CD004509
          • Davis S.R.
          • Goldstat R.
          • Papalia M.A.
          • Shah S.
          • Kulkani J.
          • Donath J.
          • et al.
          Effects of aromatase inhibitors on sexual function and well-being in postmenopausal women treated with testosterone; a randomized, placebo-controlled trial.
          Menopause. 2006; 13: 37-45
          • Shifren J.L.
          • Braunstein G.D.
          • Simon J.A.
          • Casson P.R.
          • Buster J.E.
          • Redmond G.P.
          • et al.
          Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
          N Engl J Med. 2000; 343: 682-688
          • Buster J.E.
          • Kingsberg S.A.
          • Aguirre O.
          • Brown C.
          • Breaux J.G.
          • Buch A.
          • et al.
          Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
          Obstet Gynecol. 2005; 105: 944-952
          • Braunstein G.D.
          • Sundwall D.A.
          • Katz M.
          • Shifren J.L.
          • Buster J.E.
          • Simon J.A.
          • et al.
          Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
          Arch Intern Med. 2005; 165: 1582-1589
          • Simon J.
          • Braunstein G.
          • Nachtigall L.
          • Utian W.
          • Katz M.
          • Miller S.
          • et al.
          Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
          J Clin Endocrinol Metab. 2005; 90 (Epub 2005 Jul 12): 5226-5233
          • Davis S.R.
          • van der Mooren M.J.
          • van Lunsen R.H.
          • Lopes P.
          • Ribot C.
          • Rees M.
          • et al.
          Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized placebo-controlled trial.
          Menopause. 2006; 13: 387-396
          • Shifren J.L.
          • Davis S.R.
          • Moreau M.
          • Waldbaum A.
          • Bouchard C.
          • DeRogatis L.
          • et al.
          Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 study.
          Menopause. 2006; 13: 770-779
          • Kingsberg S.
          • Shifren J.
          • Wekselman K.
          • Rodenberg C.
          • Koochaki P.
          • De Rogatis L.
          Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
          J Sex Med. 2007; 4: 1001-1008
          • Davis S.R.
          • Moreau M.
          • Kroll R.
          • Bouchard C.
          • Panay N.
          • Gass M.
          • APHRODITE Study Team
          • et al.
          Testosterone for low libido in menopausal women not taking estrogen.
          N Engl J Med. 2008; 359: 2005-2017
          • Panay N.
          • Al-Azzawi F.
          • Bouchard C.
          • Davis S.R.
          • Eden J.
          • Lodhi I.
          • et al.
          Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
          Climacteric. 2010; 13: 121-131
          • El-Hage G.
          • Eden J.A.
          • Manga R.Z.
          A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
          Climacteric. 2007; 10: 335-343
          • Nathost-Boos J.
          • Floter A.
          • Jarkander-Rolff M.
          • Carlstrom K.
          • von Schoultz B.
          Treatment with percutaneous testosterone gel in postmenopausal women with decreased libido: effects on sexuality and psychological general well-being.
          Maturitas. 2006; 53: 11-18
          • Sante R.J.
          • Allred D.C.
          • Ardoin S.P.
          • Archer D.F.
          • Boyd N.
          • Braunstein G.D.
          • et al.
          Postmenopausal hormone therapy: an Endocrine Society scientific statement.
          J Clin Endocrinol Metab. 2010; 95: S1-S66
          • Al-Imari L.
          • Wolfman W.L.
          The safety of testosterone therapy in women.
          J Obstet Gynaecol Can. 2012; 34: 859-865
          • Davis S.R.
          • Braunstein G.D.
          Efficacy and safety of testosterone in HSDD.
          J Sex Med. 2012; 9: 1134-1148
          • Nachtigall L.
          • Casson P.
          • Lucas J.
          • Schofield V.
          • Melson C.
          • Simon J.A.
          Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen.
          Gynecol Endocrinol. 2011; 27: 39-48
          • van Staa T.P.
          • Sprafka J.M.
          Study of adverse outcomes in women using testosterone therapy.
          Maturitas. 2009; 62 (Epub 2008 Dec 24): 76-80
          • Nijland E.A.
          • Weijmar Schultz W.C.
          • Nathorst-Boös M.
          • Helmond F.A.
          • Van Lunsen R.H.
          • Palacios S.
          • et al.
          Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
          J Sex Med. 2008; 5: 646-656
          • Panjari M.
          • Davis S.R.
          DHEA for postmenopausal women: a review of the evidence.
          Maturitas. 2010; 66: 172-179
          • Labrie F.
          • Archer D.
          • Bouchard C.
          • Fortier M.
          • Cusan L.
          • Gomez J.L.
          • et al.
          Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
          Menopause. 2009; 16: 923-931
          • Management of symptomatic vulvovaginal atrophy
          2013 position statement of The North Amerian Menopause Society.
          Menopause. 2013; 20: 888-902
          • Maserejian N.N.
          • Shifren J.
          • Parish S.J.
          • Segraves R.T.
          • Huang L.
          • Rosen R.C.
          Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women.
          J Sex Marital Ther. 2012; 38: 41-62
          • Berman J.R.
          • Berman L.A.
          • Lin H.
          • Flaherty E.
          • Lahey N.
          • Goldstein I.
          • et al.
          Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder.
          J Sex Marital Ther. 2001; 27: 411-420
          • Basson R.
          • McInnes R.
          • Smith M.D.
          • Hodgson G.
          • Koppiker N.
          Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.
          J Womens Health Gend Based Med. 2002; 11: 367-377
          • Billups K.L.
          • Berman L.
          • Berman J.
          • Metz M.E.
          • Glennon M.E.
          • Goldstein I.
          A new non-pharmacological vacuum therapy for female sexual dysfunction.
          J Sex Marital Ther. 2001; 27: 435-441
          • Basson R.
          • Brotto L.A.
          Sexual psychophysiology and effects of sildenafil citrate in estrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trail.
          BJOG. 2003; 110: 1014-1024
          • Nurnberg H.G.
          • Hensley P.L.
          • Heiman J.R.
          • Croft H.A.
          • Debattista C.
          • Paine S.
          Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.
          JAMA. 2008; 300: 395-404
          • Sipski M.I.
          • Rosen R.C.
          • Alexander L.J.
          • Hamer R.M.
          Sildenafil effects on sexual and cardiovascular reponses in women with spinal cord injury.
          Urology. 2000; 55: 812-815
          • Freeman E.W.
          Associations of depression with the transition to menopause.
          Menopause. 2010; 17: 823-827
          • Murell S.A.
          • Himmelfarb S.
          • Wright K.
          Prevalence of depression and its correlates in older adults.
          Am J Epidemiol. 1983; 117: 173-185
          • Clayton A.H.
          • Ninan P.T.
          Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women.
          Prim Care Companion J Clin Psychiatry. 2010; 12 (PCC.08r00747)
          • Harlow B.L.
          • Wise L.A.
          • Otto M.W.
          • Soares C.N.
          • Cohne L.S.
          Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: The Harvard Study of Moods and Cycles.
          Arch Gen Psychiatry. 2003; 60: 29-36
          • Werneke U.
          • Northey S.
          • Bhugra D.
          Antidepressants and sexual dysfunction.
          Acta Psychiatr Scand. 2006; 114: 385-397
          • Johannes C.B.
          • Clayton A.H.
          • Odom D.M.
          • Rosen R.C.
          • Russo P.A.
          • Shifren J.L.
          • et al.
          Distressing sexual problems in United States women revisited: prevalence after accounting for depression.
          J Clin Psychiatry. 2009; 70: 1698-1706
          • Fooladi E.
          • Bell R.J.
          • Davis S.R.
          Management strategies in SSRI-associated sexual dysfunction in women at midlife.
          Climacteric. 2012; 15: 306-316
          • Clayton A.H.
          • Warnock J.K.
          • Kornstein S.G.
          • Pinkerton R.
          • Sheldon-Keller A.
          • McGarvey E.L.
          A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.
          J Clin Psychiatry. 2004; 65: 62-67
          • Kingsberg S.
          The impact of premature ovarian insufficiency on sexual function.
          Menopause. 2011; 18: 246-247
          • Kalantaridou S.N.
          • Vanderhoof V.H.
          • Calis K.A.
          • Corrigan E.C.
          • Troendle J.F.
          • Nelson L.M.
          Sexual function in young women with spontaneous 46XX primary ovarian insufficiency.
          Fertil Steril. 2008; 90: 1805-1811
          • Van der Stege J.G.
          • Groen H.
          • van Zadelhoff S.J.
          • Lambalk C.B.
          • Braat D.D.
          • van Kasteren Y.M.
          • et al.
          Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure.
          Menopause. 2008; 15: 23-31
          • de Almeida D.M.
          • Benetti-Pinto C.L.
          • Makuch M.Y.
          Sexual function of women with premature ovarian failure.
          Menopause. 2011; 18: 262-266
          • Anderson W.F.
          • Chatterjee N.
          • Ershler W.B.
          • Brawley O.W.
          Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.
          Breast Cancer Res Treat. 2002; 76: 27-36
          • American College of Obstetricians and Gynecologists
          • Committee on Practice Bulletins—Gynecology
          Management of gynecologic issues in women with breast cancer. Practice Bulletin No. 126, March 2012.
          Obstet Gynecol. 2012; 119: 666-682
          • Gilbert E.
          • Ussher J.M.
          • Perz J.
          Sexuality after breast cancer: a review.
          Maturitas. 2010; 66: 397-407
          • Bradford A.
          Sexual outcomes of aromatase inhibitor therapy in women with breast cancer: time for intervention.
          Menopause. 2013; 20: 128-129
          • Panjari M.
          • Bell R.J.
          • Davis S.R.
          Sexual function after breast cancer.
          J Sex Med. 2011; 8: 294-302
          • Baumgart J.
          • Nilsson K.
          • Stavreus Evers A.
          • Kunovac Kallak T.
          • Sundström Poromaa I.
          Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer.
          Menopause. 2013; 20: 162-168
          • Kendall A.
          • Dowsett M.
          • Folkerd E.
          • Smith I.
          Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.
          Ann Oncol. 2006; 17 (Epub 2006 Jan 27): 584-587
          • Pfeiler G.
          • Glatz C.
          • Konigsberg R.
          • Geisendorfer T.
          • Fink-Retter A.
          • Kubista E.
          • et al.
          Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
          Climacteric. 2011; 14: 339-344
          • Bober S.L.
          • Varela V.S.
          Sexuality in adult cancer survivors: challenges and intervention.
          J Clin Oncol. 2012; 30: 3712-3719
          • Hatzichristou D.
          • Rosen R.C.
          • Derogatis L.R.
          • Low W.Y.
          • Meuleman E.J.
          • Sadovsky R.
          • et al.
          Recommendations for the clinical evaluation of men and women with sexual dysfunction.
          J Sex Med. 2010; 7: 337-348